Skip to main content

Nexus Pharmaceuticals Launches Fluorescein 2 mL

Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial. Nexus is committed to enhancing the availability of Fluorescein across the optometry market.

Fluorescein 2 mL and 5 mL are available in cartons of ten. Order your supply of 2 mL Fluorescein Injection, USP 25% directly through your Wholesalers or from Customer Service at (888) 806-4606.

Unit of sale NDC: 14789-0123-05

  • Cencora – 10298239
  • Cardinal – 5977483
  • McKesson – 3020054
  • Morris & Dickson - 594374

About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.64
+2.08 (1.00%)
AAPL  274.23
+2.09 (0.77%)
AMD  210.86
-2.98 (-1.39%)
BAC  51.69
+1.28 (2.54%)
GOOG  313.03
+2.11 (0.68%)
META  653.69
+14.39 (2.25%)
MSFT  400.60
+11.60 (2.98%)
NVDA  195.56
+2.71 (1.41%)
ORCL  147.89
+1.75 (1.20%)
TSLA  417.40
+8.02 (1.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.